Through the transaction, NextGen shareholders will receive $23.95 per share in cash. The company’s stock will be removed from the Nasdaq exchange, according to a Nov. 10 Thoma Bravo news release.
The private equity group first announced the transaction in September.
“We are delighted to partner with Thoma Bravo to accelerate the delivery of transformational solutions to the ambulatory healthcare marketplace,” NextGen CEO and President David Sides said in the news release. “Our employees, clients and partners are unified behind our vision of achieving Better Healthcare Outcomes for All. By combining our deep healthcare domain expertise with Thoma Bravo’s renowned operational expertise, we believe we can deliver on that vision faster.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
